Immunopathogenesis, Diagnosis, and Treatment of Multiple Sclerosis - Neurologic Clinics Skip
to Main Content Advertisement Neurologic Clinics Log in Register Log in Subscribe Claim Skip …

Abstract Background Multiple Sclerosis (MS) is a demyelinating disease of the central
nervous system (CNS). The most common type of MS is the relapsing–remitting MS (RRMS) …

Background Chronological age is associated with disability accumulation in multiple
sclerosis (MS). Biological age may give more precise estimates of aging pathways …

Background and purpose Despite the 2017 revisions to the McDonald criteria, diagnosing
primary progressive multiple sclerosis (PPMS) remains challenging. To improve clinical …

Background Primary progressive multiple sclerosis (PPMS) is characterised by gradual
worsening of disability from symptom onset. Knowledge about the natural course of PPMS …

Background Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease
that causes significant disabilities. Latest MS epidemiological data in Australia reveal rising …

Background A contemporary understanding of disability evolution in multiple sclerosis (MS)
is an essential tool for individual disease management and planning of interventional …

Multiple sclerosis (MS) is a chronic autoimmune inflammatory and neurodegenerative
disease of the central nervous system, which is characterized by significant clinical …

Multiple sclerosis (MS) is an autoimmune disease primarily affecting the central nervous
system, commonly diagnosed in women and individuals of European ancestry. It most …

Several treatments for the acute inflammatory manifestations of multiple sclerosis (MS) were
identified using the strategy of conducting a phase 2 study with an imaging-based biomarker …